Inverse correlations between BMI and PDE activities have been observed in subcutaneous and omental AT (43) and inhibition of PDE4 has been identified as a therapeutic target for obese women with polycystic ovary syndrome (44). This evidence concerns the gene PDE4A and polycystic ovary syndrome.